Gwt-tud Gmbh

This study tests a drug called luspatercept in 70 adults with a low-risk form of myelodysplastic syndromes (MDS) that includes ring sideroblasts. The goal is to see if the drug can reduce or eliminate the need for red blood cell transfusions. Participants receive the drug as an i…

This study tests whether adding a targeted drug (polatuzumab vedotin) to standard chemotherapy helps people with diffuse large B-cell lymphoma that has come back or not responded to initial treatment. About 306 adults will receive either the new combo or standard therapy. The goa…